Global Contrast Media Injector in Vascular 麻豆原创 Research Report 2025

Publication ID:

PB501253681

Publication Date:

January 15, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Contrast Media Injector in Vascular was valued at US$ 113 million in the year 2024 and is projected to reach a revised size of US$ 132 million by 2031, growing at a CAGR of 2.3% during the forecast period.
Contrast delivery is most effective and efficient using a medical device called a 鈥減ower injector鈥� that can be programmed to deliver specific amounts of contrast media. This 鈥減ower injector鈥� is the Contrast Injector.
Contrast Media Injector in Vascular can be used to look at the arteries or veins in the head, arms, legs, chest, back, or belly.
Global Contrast Media Injector in Vascular key players include Bayer, Bracco, Guerbet, etc. Global top three manufacturers hold a share over 55%.
Europe is the largest market, with a share about 50%, followed by Japan, and North America, both have a share over 45 percent.
In terms of product, Dual-head Contrast Media Injector in Vascular is the largest segment, with a share over 75%. And in terms of application, the largest application is Cardiology, followed by Oncology, Neurology, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contrast Media Injector in Vascular, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contrast Media Injector in Vascular.
The Contrast Media Injector in Vascular market size, estimations, and forecasts are provided in terms of sales volume (Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Contrast Media Injector in Vascular market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contrast Media Injector in Vascular manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bayer
Bracco
Nemoto
Guerbet
Ulrich medical
MEDTRON
APOLLO RT
Anke High-Tech
Segment by Type
Single-head Contrast Media Injector
Dual-head Contrast Media Injector
Segment by Application
Cardiology
Oncology
Neurology
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Contrast Media Injector in Vascular manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Contrast Media Injector in Vascular in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Contrast Media Injector in Vascular 麻豆原创 Overview
1.1 Product Definition
1.2 Contrast Media Injector in Vascular by Type
1.2.1 Global Contrast Media Injector in Vascular 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Single-head Contrast Media Injector
1.2.3 Dual-head Contrast Media Injector
1.3 Contrast Media Injector in Vascular by Application
1.3.1 Global Contrast Media Injector in Vascular 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Cardiology
1.3.3 Oncology
1.3.4 Neurology
1.4 Global Contrast Media Injector in Vascular 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Contrast Media Injector in Vascular Revenue 2020-2031
1.4.2 Global Contrast Media Injector in Vascular Sales 2020-2031
1.4.3 Global Contrast Media Injector in Vascular 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Contrast Media Injector in Vascular 麻豆原创 Competition by Manufacturers
2.1 Global Contrast Media Injector in Vascular Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Contrast Media Injector in Vascular Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Contrast Media Injector in Vascular Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Contrast Media Injector in Vascular, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Contrast Media Injector in Vascular, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Contrast Media Injector in Vascular, Product Type & Application
2.7 Global Key Manufacturers of Contrast Media Injector in Vascular, Date of Enter into This Industry
2.8 Global Contrast Media Injector in Vascular 麻豆原创 Competitive Situation and Trends
2.8.1 Global Contrast Media Injector in Vascular 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Contrast Media Injector in Vascular Players 麻豆原创 Share by Revenue
2.8.3 Global Contrast Media Injector in Vascular 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Contrast Media Injector in Vascular 麻豆原创 Scenario by Region
3.1 Global Contrast Media Injector in Vascular 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Contrast Media Injector in Vascular Sales by Region: 2020-2031
3.2.1 Global Contrast Media Injector in Vascular Sales by Region: 2020-2025
3.2.2 Global Contrast Media Injector in Vascular Sales by Region: 2026-2031
3.3 Global Contrast Media Injector in Vascular Revenue by Region: 2020-2031
3.3.1 Global Contrast Media Injector in Vascular Revenue by Region: 2020-2025
3.3.2 Global Contrast Media Injector in Vascular Revenue by Region: 2026-2031
3.4 North America Contrast Media Injector in Vascular 麻豆原创 Facts & Figures by Country
3.4.1 North America Contrast Media Injector in Vascular 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Contrast Media Injector in Vascular Sales by Country (2020-2031)
3.4.3 North America Contrast Media Injector in Vascular Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Contrast Media Injector in Vascular 麻豆原创 Facts & Figures by Country
3.5.1 Europe Contrast Media Injector in Vascular 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Contrast Media Injector in Vascular Sales by Country (2020-2031)
3.5.3 Europe Contrast Media Injector in Vascular Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contrast Media Injector in Vascular 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Contrast Media Injector in Vascular 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Contrast Media Injector in Vascular Sales by Region (2020-2031)
3.6.3 Asia Pacific Contrast Media Injector in Vascular Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Contrast Media Injector in Vascular 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Contrast Media Injector in Vascular 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Contrast Media Injector in Vascular Sales by Country (2020-2031)
3.7.3 Latin America Contrast Media Injector in Vascular Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contrast Media Injector in Vascular 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Contrast Media Injector in Vascular 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Contrast Media Injector in Vascular Sales by Country (2020-2031)
3.8.3 Middle East and Africa Contrast Media Injector in Vascular Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Contrast Media Injector in Vascular Sales by Type (2020-2031)
4.1.1 Global Contrast Media Injector in Vascular Sales by Type (2020-2025)
4.1.2 Global Contrast Media Injector in Vascular Sales by Type (2026-2031)
4.1.3 Global Contrast Media Injector in Vascular Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Contrast Media Injector in Vascular Revenue by Type (2020-2031)
4.2.1 Global Contrast Media Injector in Vascular Revenue by Type (2020-2025)
4.2.2 Global Contrast Media Injector in Vascular Revenue by Type (2026-2031)
4.2.3 Global Contrast Media Injector in Vascular Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Contrast Media Injector in Vascular Price by Type (2020-2031)
5 Segment by Application
5.1 Global Contrast Media Injector in Vascular Sales by Application (2020-2031)
5.1.1 Global Contrast Media Injector in Vascular Sales by Application (2020-2025)
5.1.2 Global Contrast Media Injector in Vascular Sales by Application (2026-2031)
5.1.3 Global Contrast Media Injector in Vascular Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Contrast Media Injector in Vascular Revenue by Application (2020-2031)
5.2.1 Global Contrast Media Injector in Vascular Revenue by Application (2020-2025)
5.2.2 Global Contrast Media Injector in Vascular Revenue by Application (2026-2031)
5.2.3 Global Contrast Media Injector in Vascular Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Contrast Media Injector in Vascular Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Contrast Media Injector in Vascular Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Bracco
6.2.1 Bracco Company Information
6.2.2 Bracco Description and Business Overview
6.2.3 Bracco Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bracco Contrast Media Injector in Vascular Product Portfolio
6.2.5 Bracco Recent Developments/Updates
6.3 Nemoto
6.3.1 Nemoto Company Information
6.3.2 Nemoto Description and Business Overview
6.3.3 Nemoto Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nemoto Contrast Media Injector in Vascular Product Portfolio
6.3.5 Nemoto Recent Developments/Updates
6.4 Guerbet
6.4.1 Guerbet Company Information
6.4.2 Guerbet Description and Business Overview
6.4.3 Guerbet Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Guerbet Contrast Media Injector in Vascular Product Portfolio
6.4.5 Guerbet Recent Developments/Updates
6.5 Ulrich medical
6.5.1 Ulrich medical Company Information
6.5.2 Ulrich medical Description and Business Overview
6.5.3 Ulrich medical Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ulrich medical Contrast Media Injector in Vascular Product Portfolio
6.5.5 Ulrich medical Recent Developments/Updates
6.6 MEDTRON
6.6.1 MEDTRON Company Information
6.6.2 MEDTRON Description and Business Overview
6.6.3 MEDTRON Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2020-2025)
6.6.4 MEDTRON Contrast Media Injector in Vascular Product Portfolio
6.6.5 MEDTRON Recent Developments/Updates
6.7 APOLLO RT
6.7.1 APOLLO RT Company Information
6.7.2 APOLLO RT Description and Business Overview
6.7.3 APOLLO RT Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2020-2025)
6.7.4 APOLLO RT Contrast Media Injector in Vascular Product Portfolio
6.7.5 APOLLO RT Recent Developments/Updates
6.8 Anke High-Tech
6.8.1 Anke High-Tech Company Information
6.8.2 Anke High-Tech Description and Business Overview
6.8.3 Anke High-Tech Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Anke High-Tech Contrast Media Injector in Vascular Product Portfolio
6.8.5 Anke High-Tech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contrast Media Injector in Vascular Industry Chain Analysis
7.2 Contrast Media Injector in Vascular Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contrast Media Injector in Vascular Production Mode & Process Analysis
7.4 Contrast Media Injector in Vascular Sales and 麻豆原创ing
7.4.1 Contrast Media Injector in Vascular Sales Channels
7.4.2 Contrast Media Injector in Vascular Distributors
7.5 Contrast Media Injector in Vascular Customer Analysis
8 Contrast Media Injector in Vascular 麻豆原创 Dynamics
8.1 Contrast Media Injector in Vascular Industry Trends
8.2 Contrast Media Injector in Vascular 麻豆原创 Drivers
8.3 Contrast Media Injector in Vascular 麻豆原创 Challenges
8.4 Contrast Media Injector in Vascular 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bayer
Bracco
Nemoto
Guerbet
Ulrich medical
MEDTRON
APOLLO RT
Anke High-Tech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.